Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Innovative Medtech ( (IMTH) ).
Innovative MedTech, Inc. has announced its entry into the advanced wound care market by signing consulting agreements with experts to manage the expansion and pursue major opportunities outside its current system. The company is also acquiring CyberHealthAI, a cutting-edge AI/VR system designed to enhance healthcare services, with sales and licensing expected to commence in the second quarter of 2025. Furthermore, IMTH is advancing in oral care through a collaboration with Texas A&M University for a bioequivalence study of its licensed Oral Thrush treatment, aiming to seize a share of the growing market for oral candidiasis treatments.
More about Innovative Medtech
Innovative MedTech, Inc. operates in the healthcare industry and is focused on providing advanced wound care services. The company is expanding its services to include biological amnionic membrane allografts, which are highly effective in healing infected wounds. IMTH also holds an 80% ownership stake in a subsidiary focused on distributing treatment for oral thrush.
YTD Price Performance: -1.14%
Average Trading Volume: 683
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $12.14M
See more insights into IMTH stock on TipRanks’ Stock Analysis page.
Trending Articles
- Apple Settles $95M Class Action Suit and Clears Siri’s Privacy Norms
- Biden Plans One Last Chip Export Curb on Nvidia Before Leaving Office
- 3 Penny Stocks to Watch Now, 1/9/25
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
